The future of devices diabetes care in 2016 – the key demand drivers remain intact

new research report GBI, "The Future Devices Market Diabetes Care 2016 – the main demand drivers remain intact," provides key data, information and analysis on the World market devices diabetes care, a key segment in the medical equipment industry This physician. device report provides overview of market, competitive landscape information and market trends in two categories of devices diabetes care market – glycemic control and management insulin. The report provides detailed information on key trends affecting this category, and content analysis of the dynamics of key market. The report also examines the competitive landscape, key pipeline products and technology offerings. This report builds on data and information proprietary databases, primary and secondary research and analysis in-house by the GBI team search experts in the industry.

Scope
• key geographies, including the United States (U.S.) Canada, United Kingdom (UK), Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
• global market size and share corporate data for categories of diabetes care devices market three – control of blood glucose and insulin.
• Annualized revenue from market data from 2002 to 2009, forecasts for 7 years before 2016. The Company's shares data 2008.
• Qualitative analysis of key market trends, market drivers and restrictions on categories and segments.
• Overview competition and key company profiles. The key players discussed include Roche, LifeScan, Bayer, Abbott, Becton, Dickinson Medtronic, Novo Nordisk, Sanofi-Aventis, Eli Lilly, ARKRAY, Terumo, Animas, and Smiths Medical.
• mains products and technology should reach the overall management of the diabetes market devices in the near future.

Reasons to buy
• Develop business strategies by trends and developments that are causing the market devices diabetes worldwide.
• Design and development of its product development, marketing and sales strategies.
• Take advantage of opportunities through the identification of M & A market players with the most innovative pipeline.
• Develop market access and market expansion strategies.
• Identify key players in the best position to exploit new opportunities.
• Build on the licensing and opportunities licensing product identification, most likely to ensure a solid return.
• What is the next big thing in the landscape diabetes care devices market? – Identify, understand and use.
• Make more informed business decisions insightful analysis and depth market for diabetes care devices and the factors that determine them.

1 Content

1.1 List of Tables 7
1.2 List of Figures 9

2 Introduction and Overview In general 11
2.1 Diabetes Type 1 November
2.2 Diabetes Type 2 November
Diabetes 2.3 accentuation of the disease cardiovascular 11
2.3.1 Atherosclerosis 11
11 2.3.2 diabetic cardiomyopathy
2.3.3 Carrera 11
2.3.4 12 kidney disease
2.4 the diabetes, a charge for 12 Health expenditure
2.5 Prevalence and incidence of diabetes 12
World 2.5.1 12
2.5.2 Prevalence of diabetes in developing countries 13

3 Diabetes Care Devices Market: Market Characterization 14
World 3.1 Diabetes Care Devices Market, income (dollars) from 2002 to 2009 14
3.2 Diabetes Care Devices Global Market Forecast Revenue (million dollars) from 2.009 to 2.016 15
3.3 Care Devices Diabetes, Key Market Trends 15
3.3.1 Growth in Home Health Market Conduct devices Diabetes Care 15
3.3.2 Brand loyalty on devices diabetes care: it is difficult to 16
3.3.3 The no market repayment problems 16
3.3.4 Drug Stores to remain the major distribution channels 16
3.4 The provisions of diabetes care: Technology Trends 17
3.4.1 Improving the lives of 17
3.4.2 continuous glucose monitoring (CGM) 18
3.4.3 disposable insulin pumps 18
3.4.4 Pain Control Devices Free Will drive future growth in the market for devices Care Diabetes 20
3.4.5 The increasing demand for insulin devices without pain 21
3.4.6 Remote Monitoring: Increased compliance with diabetes 21
3.5 Provisions care of diabetes, 22 Market Drivers
3.5.1 New technologies to increase sales 22
3.5.2 increasing prevalence of diabetes to increase sales 23
3.5.3 The aging of the fastest growing population in the world to increase the population of 25 patients
3.5.4 Introduction of new generation aircraft stimulate the market for glucose monitoring 25
3.5.5 Increased awareness of better management of diabetes 26
3.5.6 Lifestyle Changes greater prevalence of diseases in 26
3.5.7 Product Innovation 26, to increase acceptance
26 3.6 Restrictions
3.6.1 The lack of financial ability and knowledge of countries 26 developing
3.6.2 The lack of reimbursement of new technologies 26
3.6.3 diagnostic rates of 26
3.6.4 The lowest compliance of 27 patients
3.6.5 overall cost is a restraint system for insulin pens and pumps 27
3.6.6 Other factors affecting the management of diabetes aviation market 27
3.6.7 Low market penetration affecting growth 27
World 3.7 Diabetes Care Devices Market, the key actions (%) 2008 28

4 Diabetes Care Devices Global Market: Market Analysis and 29 Cross Segment forecast
4.1 The glucose monitoring market 29
4.1.1 The global market for glucose monitoring, revenue ($ m) 2002 – 2009 29
4.1.2 The global market for glucose monitoring, revenue forecasts ($ m) 2009-2016 30
4.1.3 Market Drivers 30
4.1.4 Market Restraints 31
4.1.5 The glucose monitoring market, the 32-segment revenue
4.1.6 Meters Blood Glucose market dynamics 33
4.1.7 Test blood glucose strips 34 Market Income
4.1.8 Glucose Test Strips blood market dynamics 35
4.2 Safety of insulin 36
4.2.1 Insulin World Revenue ($ m), World, 2002 – 2009 37
4.2.2 World Insulin income ($ m), Global, 2009 to 2016 38
4.2.3 Market Drivers 38
4.2.4 Market Restraints 39
Income Market 40 4.2.5 Insulin Pumps
4.2.6 Insulin pumps, income ($ m) Global Forecast 41
4.2.7 Market Dynamics 41 insulin pumps
4.2.8 Revenue market pen-injectors 42
4.2.9 Insulin pens market dynamics 44
02/04/1910 insulin syringes, 44 Market Revenue
04/02/1911 45 insulin syringes market dynamics

5 devices diabetes care: Competitive Landscape 46
5.1 The delivery of insulin competitive landscape 46
5.1.1 Strategic Review of 46 competitors
5.1.2 Characteristics of insulin, Company Share Analysis (%) 2008 47
5.2 The 47 key enterprises
5.2.1 Becton, Dickinson and Company 47
5.2.2 Medtronic 47
5.2.3 Novo Nordisk 47
5.2.4 Other 48
Insulet Corporation 48 5.2.5
5.2.6 NiliMEDIX 48
Medingo Ltd 48 5.2.7
48 Debiotech SA 5.2.8
48 5.2.9 Company Phlu
02/05/1910 48 Value Inc.
Insulin Medical Ltd 48 05/02/1911
Aradigm Corporation 05/02/1912 48
MannKind Corporation 02/05/1913 49
Altea Therapeutics Corporation 02/05/1914 49
5.3 Monitoring glucose system market: Assessment of Competence 49
5.3.1 Description 49
5.3.2 Evaluation 49 strategic competitors
5.3.3 Glucose Monitoring Systems in shares of the Company 2008 50
5.3.4 F. Hoffmann-La Roche Ltd. 50
5.3.5 LifeScan (Johnson & Johnson) 51
Bayer Healthcare 51 5.3.6
51 5.3.7 Abbott Laboratories
5.3.8 Profiles of major products marketed products in the market for monitoring systems of glucose of 52
53 OneTouch ® UltraMini 5.3.9
03/05/1910 54 Contour

6 Diabetes Care global device market: forecast analysis cross-country and 55
6.1 The entry into the country from 2002 to 2009 55
6.1.1 The United States Diabetes Care Devices Market, income (dollars) 2002 – 2009 55
6.1.2 Diabetes Care Devices Market in Canada, Revenue ($ M), 2002 – 2009 56
6.1.3 The United Kingdom Diabetes Care Devices market income (dollars), 2002 – 2009 57
Devices 6.1.4 Diabetes Care in Germany market, income (dollars), 2002 – 2009 58
6.1.5 Diabetes Care Devices Market France, Revenue (million dollars) 2002 – 2009 59
6.1.6 Italy Diabetes Care Devices Market products (In millions of dollars) 2002 – 2009 60
6.1.7 Spain Diabetes Care Devices Market, income (dollars), 2002 – 2009 61
6.1.8 Japan Diabetes devices care market, revenue ($ m), from 2002 to 2009 62
6.1.9 China Diabetes Care Devices Market, production (dollars) 2002 – 2009 63
06/01/1910 India Diabetes Care Devices Market, income (dollars), 2002 – 2009 64
06.01.1911 Australia Diabetes Care Devices market goods (million dollars) 2002 – 2009 65
01/06/1912 Brazil Diabetes Care Devices Market products ($ m), 2002 – 2009 66
6.2 Projections income by country between 2009 and 2016 67
6.2.1 The United States Diabetes Care Devices Market, production ($ m), from 2009 to 2016 67
6.2.2 Devices Diabetes Care Canadian market, products (U.S. dollars) from 2009 to 2016 68
6.2.3 The United Kingdom Diabetes Care Devices Market, production ($ m), 2009 to 2016 69
6.2.4 Germany Diabetes Care Devices Market, products ($ m), from 2009 to 2016 70
6.2.5 Device Diabetes Care Market France, Revenue ($ m) of 2009 to 2016 71
6.2.6 Diabetes Care Devices Market Italy, Revenue (million dollars) from 2009 to 2016 72
6.2.7 Devices in Spain Diabetes Care products market ($ m), from 2009 to 2016 73
6.2.8 Device Diabetes Care Market in Japan, the sales ($ m) 2009-2016 74
6.2.9 China Diabetes Care Devices Market, production (dollars) from 2009 to 2016 75
06/02/1910 Diabetes Care Devices Indian market, income ($ m) 2009-2016 76
02/06/1911 Australia Diabetes Care Devices Market, production ($ m), from 2009 to 2016 77
6.2.12 Brazil Diabetes Care Devices Market income (dollars) from 2009 to 2016 78

7 Devices Diabetes Care: 79 Pipeline Analysis
7.1 The products of glucose control key 79 Pipeline
Strategic Assessment 79 7.1.1 Pipeline
7.1.2 Glucose Monitoring Systems – Clinical Phase Pipeline 80 development
7.1.3 Profiles attractive candidates in clinical development 80
7.1.4 Glucose Monitoring Systems in the market: the list of 83 new products
7.1.5 Control systems of glucose by 86 Summary Product Pipeline Product Type
7.1.6 Glucose Monitoring Systems Product Pipeline Summary: Glucose Monitoring 87 home
7.1.7 Glucose Monitoring Systems Product Pipeline Summary: Hospital Systems glucose monitoring, 89-Marco
7.1.8 Systems glucose control product pipeline Summary: Both the Home and Hospital Setting systems glucose monitoring 89
7.2 Impact of Competition in the future market 90
7.3 Assessment of strategic competitors 90
7.4 Monitoring of the market system of glucose: 91 Emerging Companies
7.4.1 Introduction 91
7.5 The insulin product key delivery pipe 92
7.5.1 Description 92
7.5.2 Assessment of the strategic line 93
7.5.3 Features of insulin – Clinical pipeline through the delivery of insulin in 94
7.6 Characteristics of insulin – Clinical Pipeline by development phase 95
7.7 Summary of pipeline products 96 insulin devices
7.8 The insulin – Appliances promising in clinical development 96
7.8.1 Control of diabetes of 96 closed circuit
I see System 97 7.8.2 Paradigm
7.8.3 AERx insulin Diabetes Management System 98
7.8.4 Characteristics of insulin – Competition on the futures market 102
7.8.5 Strategic Review of 102 competitors
7.9 The reimbursement of the 103 peripheral insulin

8 Care Devices global diabetes market: 105 Consolidation of Landscape
8.1 Analysis Deal-1st quarter 2009 105
8.1.1 Device Offers Diabetes Care 1106 quarter
Deal Analysis Q2 2009 8.2 106
Devices 8.2.1 Diabetes Care – Quarter Offers, 2107
8.3 Analysis Q3 2009 108 Deal
8.3.1 Devices Diabetes Care – Find the 3 rd quarter 109
8.4 Analysis Deal – October 2009 109
8.5 Analysis of Supply – December 2009 110

9 Annex 112
9.1 Decision Support Database 112
9.1.1 Complications of diabetes with 112
9.2 devices diabetes care: Definitions 113
9.2.1 Monitoring of glucose in 113
9.2.2 Insulin 113
9.3 Methodology 113
9.3.1 Secondary Research 114
9.3.2 Primary Research 114
9.3.3 Model 115
9.3.4 Forecasts 115
9.3.5 Expert Panels 115
Contact Us 115 09.04
9.5 Disclaimer 116

1.1 List Tables
Table 1: Diabetes sweet estimated population of patients ('000 's), 2030 13
Table 2: Devices of Diabetes Care, Revenue ($ m) World 2002 – 2009 14
Table 3: Devices Diabetes Care, Revenue ($ m), Global, from 2009 to 2016 15
Table 4: Total cost vs traditional strips Continuous Glucose Monitor 16
Table 5: insulin pumps, disposable income ($ m), USA, 2005 – 2009 19
Table 6: Pumps insulin, disposable income (M $), United States, from 2009 to 2015 20
Table 7: control of glucose non-invasively 21
Table 8: The pain of the products without insulin, 2009 21
Table 9: Estimates of the prevalence of diabetes, Worldwide, 2030 23
Table 10: Prevalence of diabetes (diagnosed and undiagnosed) by group of age, United States, 2007 24
Table 11: Prevalence of diabetes (diagnosed and undiagnosed), by sex, United States 2007 25
Table 12: Population over 65 ('000 's), 2005 – 2010 25
Table 13: glucose monitoring, revenue ($ m) In general, from 2002 to 2009 29
Table 14: glucose monitoring, revenue ($ m), Global, 2009 to 2016 30
Glucose Meters Blood revenue ($ m) Global, 2000 – 2009 32: Table 15
Table 16: Measurement of blood glucose, income ($ m), Global, from 2009 to 2016 33
Table 17 test strips blood glucose, Revenue (million dollars), Worldwide, 2002 – 2009 34
Table 18: Test Strips for blood glucose, income ($ m), Global, 2009-2016 35
Table 19: Comparison 36 insulin delivery devices
Table 20: insulin, Revenue ($ m), Worldwide, 2002 – 2009 37
Table 21: Insulin Administration, revenue ($ M), Global, 2009 to 2016 38
Table 22: Insulin pumps, income ($ m), Worldwide, 2002 – 2009 40
Table 23: Insulin Pumps, income ($ M), Global, 2009 to 2016 41
Table 24: Insulin pens, income ($ m) World from 2002 to 2009 43
Table 25: Insulin pens, income ($ M), Global, from 2009 to 2016 43
Table 26: insulin syringes, income ($ m), Global 2002 to 2009 44
Table 27: insulin syringes, the income ($ m), 2009-2016 Global 45
Table 28: Diabetes Care Devices Market, Revenue ($ m), USA, 2002 – 2009 55
Table 29: Care the Canadian Diabetes devices market, income (dollars), 2002 – 2009 56
Table 30: Diabetes Care Devices Market, income (M $) the United Kingdom, 2002 – 2009 57
Table 31: Diabetes Care Devices Market, income (dollars), Germany, from 2002 to 2009 58
Table 32: Care the Diabetes market devices, income (dollars), France, from 2002 to 2009 59
Table 33: Diabetes Care Devices Market, income ($ m) Italy 2002 – 2009 60
Table 34: Diabetes Care Devices Market, income (dollars), Spain, 2002 – 2009 61
Table 35: Devices Diabetes Care market, income (dollars), Japan, 2002-2009 62
Table 36: Diabetes Care Devices Market, income (dollars) China, 2002 – 2009 63
Table 37: Diabetes Care Devices Market, Revenue ($ m), India, 2002 – 2009 64
Table 38: Diabetes Care Devices market, income ($ m) Australia, 2002 – 2009 65
Table 39: Diabetes Care Devices Market, Revenue ($ m), Brazil, 2002 – 2009 66
Table 40: Diabetes Care market arrangements, income ($ m), United States, from 2009 to 2016 67
Table 41: Diabetes Care Devices Market, income (U.S. dollars), Canada, 2009 2016 68
Table 42: Diabetes Care Devices Market, income (dollars), United Kingdom, from 2009 to 2016 69
Table 43: Diabetes Care Devices Market, income (M $), Germany, from 2009 to 2016 70
Table 44: Diabetes Care Devices market income (dollars), France from 2009 to 2016 71
Table 45: Diabetes Care Devices Market, income (dollars), Italy from 2009 to 2016 72
Table 46: Diabetes Care Devices Market, Revenue ($ M) Spain, from 2009 to 2016 73
Table 47: Diabetes Care Devices market, income (dollars), Japan, from 2009 to 2016 74
Table 48: Diabetes Care Devices Market, China, income (dollars) 2009 to 2016 75
Table 49: Diabetes Care Devices Market, Revenue ($ m), India, from 2009 to 2016 76
Table 50: Diabetes Care Devices market, income (dollars), Australia, from 2009 to 2016 77
Table 51: Diabetes Care Devices Market, Revenue ($ m), Brazil, 2009 to 2016 78
Table 52: Summary of pipeline glucose monitoring system of the product – I 83
Table 53: System blood glucose monitoring pipeline Product Summary – 84 II
Table 54: System Monitoring blood glucose Product Pipeline Summary – 85 III
Table 55: Glucose Monitoring Systems in Home Overview Product Pipeline – I-87
Table 56: Glucose Monitoring Systems Home Contents Product Pipeline – 88 II
Table 57: Hospital Surveillance System to adjust the glucose range of 89 Summary
Table 58: Home and Hospital System Glucose Monitoring Framework Overview Product Pipeline 89
Table 59: glucose monitoring companies for new products and systems 91-I
Table 60: Glucose Monitoring Systems for new businesses and products – 92 II
Table 61: Insulin Delivery Devices Pipeline Summary produced 96 World
Table 62: closed-loop system of diabetes control, 96 State Product
Table 63: closed-loop system of diabetes control, 97 Product Description
Table 64: I see Paradigm Systems, 97 Product Status
Table 65: Veo Systems Paradigm, 97 Product Description
Table 66: AERx insulin diabetes management, 98 Product Status
Table 67: AERx insulin diabetes management, 98 Product Description
Table 68: AERx insulin Diabetes Management System – Effect of inhaled insulin (AERx iDMS) More pioglitazone versus pioglitazone alone in the HbA1c in diabetic patients type in February 1999
Table 69: AERx insulin Diabetes Management System – Pre-prandial inhaled human insulin with insulin aspart sc Versus iDMS AERx diabetes type 2: At week 104, open, multicenter, randomized, followed by a 12-week extension study back to Random security and efficiency 100
Table 70: AERx insulin Diabetes Management System – High Insulin Versus iDMS AERx inhaled insulin aspart injected subcutaneously two in combination with insulin detemir in type 1 diabetes: At week 104, open, multicenter, randomized, parallel (followed by an extension of twelve weeks Random re) to investigate the efficacy and safety 101
Medical Equipment Devices, Diabetes Care, Offers: Table 71 Summary, Q2 2008 – Q1 2009 105
Table 72: Medical equipment, devices, diabetes care Offers Summary, Q2 2008 – Q2 2009 107
Table 73: Medical equipment, devices for diabetes care, Hotel Summary, Q3 2008 – Q3 2009 108
Table 74: Equipment medical devices, diabetes care, Deals Summary, April 2009-September 2009 109
Table 75: Medical equipment, devices, diabetes care Offers Summary, May 2009-October 2009 110
Table 76: medical equipment, diabetes care devices, offers Summary, June 2009-November 2009 111
Table 77: Prevalence of diabetes (diagnosed and undiagnosed), by age group, the United States, 2007 112

1.2 List of Figures
Figure 1: Device Diabetes Care, Revenue ($ m), Worldwide, 2002 – 2009 14
Figure 2: Devices of Diabetes Care, Revenue ($ m) in the World from 2009 to 2016 15
Devices glucose control, the actions of distribution channel (%) 2008 17 Figure 3:
Figure 4: Insulin Distribution Channel Shares (%) 2008 17
Figure 5: insulin pumps, disposable income ($ m), USA, 2005 – 2009 19
Figure 6: insulin pumps, Disposable Income ($ million), United States, from 2009 to 2015 20
Figure 7: The incidence of diabetes by diagnosing, United States, 2007 24
Figure 8: Population diabetic treatment, the United States, 2007 24
Figure 9: Equipment Diabetes Care Company Share (%) Global, 2008 28
Figure 10: glucose monitoring, revenue ($ m), Worldwide, 2002 – 2009 29
Figure 11: glucose monitoring, revenue ($ M), Global, from 2009 to 2016 30
Glucose Meters Blood revenue ($ m), Global, 2000-2009 32 Figure 12:
Glucose Meters Blood Revenue ($ m), Global, 2009 to 2016 Figure 13: 33
Figure 14: Blood Test Strips, income ($ m), Worldwide, 2002 – 2009 34
Figure 15: strips reactive blood glucose, income ($ m), Global, 2009 to 2016 35
Figure 16: insulin, Revenue ($ m), Worldwide, 2002 – 2009 37
Figure 17: insulin, Revenue ($ m) World from 2009 to 2016 38
Figure 18: Insulin pumps, income ($ m), Worldwide, 2002 – 2009 40
Figure 19: Pumps insulin, Revenue ($ m), Global, from 2009 to 2016 41
Figure 20: Insulin pens, income ($ m), Worldwide, 2002 – 2009 42
Figure 21: insulin pens revenue ($ m) World from 2009 to 2016 43
Figure 22: Insulin Syringes, Revenue ($ million), World Cup 2002 – 2009 44
Figure 23: Insulin syringes, income ($ m), Global 2009 to 2016 45
Figure 24: Competitive Strategic Assessment 46
Figure 25: Devices Insulin Analysis Company Shares (%) 2008 47
Figure 26: glucose monitoring, strategic assessment of competition 49
Figure 27: Glucose Monitoring Systems, the company's shares – 2008 50
Figure 28: Diabetes Care Devices Market, Revenue ($ m), USA, 2002 – 2009 55
Figure 29: Diabetes Care Devices Market, Revenue ($ million), Canada, 2002 – 2009 56
Figure 30: Diabetes Care Devices market, income ($ m), the United Kingdom, 2002 – 2009 57
Figure 31: Diabetes Care Devices Market, income (dollars), Germany 2002 – 2009 58
Figure 32: Diabetes Care Devices Market, income (dollars), France, between 2002 and 2009 59
Figure 33: Diabetes Care devices on the market, income (M $), Italy, 2002 – 2009 60
Figure 34: Diabetes Care Devices Market, income (M $), Spain, 2002 – 2009 61
Figure 35: Diabetes Care Devices Market, income (dollars), Japan, from 2002 to 2009 62
Figure 36: Diabetes Care market arrangements, income (dollars), China, 2002 – 2009 63
Figure 37: Diabetes Care Devices Market, Revenue ($ m), India, 2002 – 2009 64
Figure 38: Diabetes Care Devices Market, income (dollars), Australia, from 2002 to 2009 65
Figure 39: Warning Devices the Diabetes market rent ($ m), Brazil, 2002 – 2009 66
Figure 40: Diabetes Care Devices Market, Revenue ($ m), United States, from 2009 to 2016 67
Figure 41: Canada Diabetes Care Devices Market, income ($ m), from 2009 to 2016 68
Figure 42: Diabetes Care Devices Market, the income (dollars), United Kingdom, from 2009 to 2016 69
Figure 43: Diabetes Care 0044evices market income (dollars), Germany, since 2009 70 2016
Figure 44: Diabetes Care Devices Market, income (dollars), France from 2009 to 2016 71
Figure 45: Diabetes Care devices on the market, revenue ($ m), Italy, from 2009 to 2016 72
Figure 46: Diabetes Care Devices Market, income (dollars) Spain, from 2009 to 2016 73
Figure 47: Diabetes Care Devices Market, income (dollars), Japan, from 2009 to 2016 74
Figure 48: Diabetes Care Devices Market, income (dollars), China, from 2009 to 2016 75
Figure 49: Diabetes Care Devices Market, income ($ M), India, from 2009 to 2016 76
Figure 50: Diabetes Care Devices Market, Revenue ($ million), Australia, from 2009 to 2016 77
Figure 51: Diabetes Care Devices Market, Revenue ($ m), Brazil, from 2009 to 2016 78
Figure 52: Trends in Technology Analysis Framework 79
Figure 53: Glucose Monitoring Systems – Pipeline clinical stage of development 80
Figure 54: glucose monitoring systems for piping products of 86 Product Type
Figure 55: 90 Strategic Assessment of competitors
Analytical Framework Technology Trends 93: Figure 56
Description 94 – Trends in Technology Analysis Framework: Figure 57
Figure 58: Insulin Delivery Devices – Clinical pipeline through the delivery of insulin in 94
Figure 59: Arrangements for the development of insulin 95 clinical stage pipeline
Figure 60: contestant Strategic Review 102
Figure 61: reimbursement mechanisms of insulin 103
Insulin pens 104 – Repayment of mixture: Figure 62
Figure 63: medical equipment, devices Diabetes Care, Volume and courage to face, Q2 2008 – Q1 2009 105
Figure 64: Medical equipment, devices for diabetes care, the deal value and volume, Q2 2008 – Q2 2009 106
Figure medical equipment, devices, diabetes care, much value and number of transactions, Q3 2008 – Q3 2009 108: 65
Figure 66: Incidence of diabetes by diagnosing, United States, 2007 112
Figure 67: Population by type of diabetes treatment, United States, 2007 112
Methodology GBI Research 114: Figure 68

About the Author

The Future of the Diabetes Care Devices Market to 2016 – The Key Demand Drivers Remain Intact now Available on ReportsandReports. ReportsandReports, comprising of an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites.

Glooko MeterSync Cable $39.95 Enjoy the ease and convenience of an electronic logbook that fits your lifestyle and helps you monitor your diabetes – anytime, anywhere. With the Glooko MeterSync Cable, quickly download blood glucose readings directly from your meter into the Glooko Logbook app where you can annotate, review, and share your results. Use the app and cable to eliminate errors from manual entry of blood glucose rea…

One Touch Ultra Blue Mail Order Test Strips, 50 CT $19.99 The One Touch Ultra Test Strips 50 helps keep your blood glucose under control. With diabetics being very common, these One Touch blue test strips will allow you to constantly check the level of your blood sugar from home. It is very user friendly as it just requires a one touch function. You can comfortably view your blood glucose levels before and after meals. The blood glucose test strips requi…

LifeScan OneTouch Ultra Soft Sterile Lancets (100 Lancets) $4.30 OneTouch UltraSoft Lancets – 28 Gauge The OneTouch UltraSoft Lancets is for use with Penlet II, Penlet Plus and UltraSoft lancing devices….

OneTouch UltraMini Glucose Monitoring System 1 ea LifeScan OneTouch UltraMini Blood Glucose Monitoring System has no complicated screens, no bells, no whistles-just the number you want from Lifescan’s smallest meter. Provides accurate results in just 5 seconds. Provides a large, easy-to-read screen and simple 3 step testing. Just the right size to easily fit in you pocket or purse. Comes complete with OneTouch UltraMini Blood Glucose Meter (batte…